Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan and Temozolomide in Breast Cancer with Brain Metastases
NCT00617539Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Feb 2005
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan, temozolomide in breast cancer, sponsored by University of California, San Francisco. Started Feb 2005; status: completed.
02
Drugs
irinotecantemozolomide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00617539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00617539.